Ridhi Tariyal

Ridhi Tariyal launched NextGen Jane, a women's health startup, while serving as a Blavatnik Fellow (2013 - 2014) at Harvard. She is co-inventor and co-conspirator of the company's technology (a smart tampon platform), which will be used to empower women with the tools to take more active ownership of their health. Prior to founding NextGen Jane, Ridhi helped establish the Lassa fever program in West Africa for the Broad Institute and led finances and operations of a genome wide association study in Sierra Leone and Nigeria. Ms. Tariyal’s career has focused on commercializing innovations in the life sciences to improve healthcare outcomes. She has expertise in emerging markets research operations (India, Africa) and women’s reproductive health and fertility. She holds an MBA, an SM Biomedical Enterprise, and a BS in Engineering.